Specialist care, connected.

Specialist Care can organise treatment cycles, clinic-supplied protocols, medication schedules, procedures, laboratory reports and follow-up outcomes. Each clinical item should remain attributable to its source.

No. The treating fertility team remains responsible for protocols, prescriptions, dose changes and monitoring. Specialist Care records the instructions supplied by that team.

No. Fertility-treatment outcomes vary with many individual and clinical factors. Specialist Care organises information and does not forecast an individual result.

The proposed workflow can organise embryo images, time-lapse information, morphology, development timing and agreed clinical metadata provided by the clinic.

No. It is designed to support assessment. A qualified embryologist and fertility team retain responsibility for interpretation, embryo selection and treatment decisions.

Not as an autonomous clinical decision. Any assessed output must remain reviewable by a qualified embryologist, with the clinic retaining responsibility for embryo-selection decisions.

Access depends on the member's permission, the clinic workflow and the governance of the deployed service. The record should not make laboratory information available beyond that authorised scope.

The pathway brings education, testing context, clinic comparison, timing, financial preparation and emotional support into one pathway. A fertility clinician remains responsible for medical advice.

No. Outcomes vary with age at freezing, number and quality of eggs, laboratory factors, future health and treatment circumstances. No page should imply a guarantee.

Shiora can keep clinic-supplied results beside counselling, timing and your questions. A fertility clinician remains responsible for interpreting what a result means for that individual.

The pathway can consider selected health information, life stage, goals, diet, medicines, allergies and relevant at-home test results. A qualified professional should review the final plan.

Yes. Supplements can interact with prescription medicines, other supplements and health conditions. A complete medication review is important before starting.

Professional involvement is especially important for pain, incontinence, injury, surgery, pregnancy-related concerns or uncertainty about correct device use.

With explicit consent, relevant progress information can support the Intimate Health pelvic-health pathway or the strength and mobility pathway in Prevention and Vitality.

No. Milestones vary and a tracker cannot diagnose a developmental condition. Concerns should be discussed with an appropriately qualified pediatric professional.

A deployed service should use clear parental consent, role-based access, age-appropriate retention and transparent controls for what is recorded and shared.

Some results may be released with clear reference information, while others require review by a licensed professional. The pathway should state which applies before purchase.

A laboratory test can provide useful information, but diagnosis often requires symptoms, history, examination or additional testing. Do not make treatment decisions from one result alone.

Add only the information relevant to the selected pathway. That may include clinic instructions, cycle dates, medicines, laboratory reports, supplement context, a professional movement plan, parenting notes or an at-home test result. Each clinical item should retain its source.

With permission, cycle history recorded through Cycles and Pregnancy can remain available beside fertility treatment and preservation information, so the treatment record does not begin without the history that preceded it.

The Shiora model is permission led. A member should be able to choose the relevant information and recipient rather than making the entire longitudinal record visible by default.